Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
about
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.Informative gene network for chemotherapy-induced peripheral neuropathyThe association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapy.Metabolic behavior prediction of pazopanib by cytochrome P450 (CYP) 3A4 by molecular docking.Rethinking ovarian cancer genomics: where genome-wide association studies stand?Genetic markers of cisplatin-induced hearing loss in children.Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer.Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
P2860
Q34797430-DC254829-ACC5-4A16-A719-5136E59B4363Q34982250-75BF2551-0315-443E-ACB6-E95C9D9D356AQ35945680-7116D2CA-FD4E-47F6-8C45-45BBE39EFAA6Q38632738-8D3B68C0-2C88-4E76-A58A-CC312C8A3C84Q41304112-FD898498-CACB-4B1F-A9B6-4DFF0D355665Q47592913-D2153978-36E9-4EF9-86E3-178F5E6091D1Q50354505-9BE87F4F-8FED-4C9A-A4CE-0C9A5624E344Q51436755-705A8671-E431-4602-8581-F93832CD2507Q55020843-FB35E79B-525D-4D46-8D0C-40680F29C8AFQ57490969-89ED785A-E311-49C4-85B7-528A11CBA0D8
P2860
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@en
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@nl
type
label
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@en
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@nl
prefLabel
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@en
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
@en
P2093
Alexey A Moisseev
Andrey V Khrunin
Denis V Khokhrin
Svetlana A Limborska
Vera A Gorbunova
P2860
P304
P356
10.2217/PGS.13.237
P577
2014-02-01T00:00:00Z